Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
PHASE3CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
August 31, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Conditions
Diabetes Mellitus Type II
Interventions
DRUG
e.-coli-nissle
1 ml qd for 24 weeks
Trial Locations (1)
01307
Carus-Hausarztpraxis, Dresden
All Listed Sponsors
collaborator
Ardeypharm GmbH
INDUSTRY
lead
GWT-TUD GmbH
OTHER
NCT02144948 - Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II | Biotech Hunter | Biotech Hunter